Top 10 Companies in the (S)-2‑Hexanol Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global (S)-2‑Hexanol market was valued at USD 28.4 million in 2025. The forecast period anticipates growth to USD 48.7 million by 2034, with a 6.2% compound annual growth rate.

(S)-2‑Hexanol is a chiral secondary alcohol (C₆H₁₄O) distinguished by its stereochemical configuration at the second carbon. It functions as a key building block and chiral intermediate in asymmetric synthesis, with applications spanning flavors and fragrances, agrochemicals, and pharmaceuticals. Its mild odor and reactivity make it suitable for specialty chemical synthesis and as a solvent component.

The market is driven by increasing demand for enantiopure compounds in drug development, expanding agrochemical uses, and the broader adoption of green chemistry principles that favor chiral intermediates for efficient synthesis. Leading producers include Sigma‑Aldrich (MilliporeSigma), TCI Chemicals, and Alfa Aesar, among other fine‑chemical manufacturers with established chiral synthesis capabilities.

(S)-2‑Hexanol Market – View in Detailed Research Report

Top 10 Companies in the (S)-2‑Hexanol Market

1. BASF SE

   Headquarters: Ludwigshafen, Germany
   Key Offering: High‑purity chiral intermediates for pharmaceuticals and fragrances

   BASF’s extensive research pipeline focuses on asymmetric hydrogenation and biocatalytic routes that deliver >99% enantiomeric excess. The company’s integrated supply chain supports rapid scale‑up for API production, positioning it as a preferred partner for pharmaceutical manufacturers seeking consistent optical purity.

   Sustainability Initiatives: Investment in enzyme‑based processes reduces energy use by 30% compared with conventional synthesis. BASF also publishes annual sustainability reports detailing life‑cycle assessments for its chiral products.

   • Advanced asymmetric catalysts
   • Biocatalytic production lines
   • ISO 9001 and ISO 14001 certifications

2. Merck KGaA

   Headquarters: Darmstadt, Germany
   Key Offering: Pharmaceutical‑grade chiral alcohols and resolving agents

   Merck’s focus on chiral chemistry aligns with its R&D strengths in drug discovery. The company’s proprietary chiral ligands enable high‑yield asymmetric synthesis, reducing process steps and waste. Merck’s collaborations with contract manufacturers expand access to its chiral intermediates across the pharmaceutical supply chain.

   Sustainability Initiatives: Commitment to circular chemistry—recycling solvents and recovering catalysts—cuts overall carbon footprint by 25%.

   • Chiral ligand development
   • Process intensification
   • Carbon‑neutral production targets

3. Tokyo Chemical Industry Co., Ltd.

   Headquarters: Tokyo, Japan
   Key Offering: Fine‑chemical chiral intermediates for agrochemicals and pharmaceuticals

   TCI leverages its advanced asymmetric hydrogenation platform to deliver chiral alcohols with high enantiomeric excess. Its strong presence in Asia‑Pacific provides regional manufacturers with timely supply, supporting local pharmaceutical R&D pipelines.

   Sustainability Initiatives: Development of low‑VOC solvent systems and waste‑minimization protocols.

   • Asymmetric hydrogenation
   • Low‑VOC solvents
   • Waste reduction programs

4. Lonza Group AG

   Headquarters: Basel, Switzerland
   Key Offering: Biocatalytic production of chiral alcohols for pharma and agrochemical applications

   Lonza’s enzymatic processes deliver high yields and purity while operating at ambient temperatures, reducing energy consumption. The company’s strong technical support and custom synthesis capabilities make it a go‑to supplier for complex API development.

   Sustainability Initiatives: Focus on renewable feedstocks and zero‑waste manufacturing.

   • Enzyme engineering
   • Renewable feedstocks
   • Zero‑waste processes

5. DSM‑Firmenich AG

   Headquarters: Uden, Netherlands
   Key Offering: Specialty chiral intermediates for fragrances and pharmaceuticals

   DSM‑Firmenich’s expertise in chiral chemistry supports the creation of high‑value fragrance notes and advanced pharmaceutical intermediates. Its global production network ensures consistent supply across key markets.

   Sustainability Initiatives: Integrated life‑cycle analysis and renewable energy usage across its facilities.

   • Fragrance chemistry
   • Pharmaceutical intermediates
   • Renewable energy integration

6. Evonik Industries AG

   Headquarters: Essen, Germany
   Key Offering: Fine‑chemical chiral building blocks for agrochemicals and pharmaceuticals

   Evonik’s portfolio includes chiral alcohols used in the synthesis of active ingredients for crop protection. The company’s continuous improvement initiatives enhance yield and reduce waste, aligning with green chemistry objectives.

   Sustainability Initiatives: Commitment to reducing CO₂ emissions by 20% over the next decade.

   • Agrochemical intermediates
   • Process optimization
   • CO₂ reduction targets

7. Thermo Fisher Scientific Inc.

   Headquarters: Waltham, USA
   Key Offering: High‑purity chiral reagents for research and development

   Thermo Fisher’s chiral reagents support academic and industrial research in drug discovery. The company’s rapid prototyping capabilities enable quick turnaround for custom chiral synthesis projects.

   Sustainability Initiatives: Focus on reducing single‑use plastics in laboratory consumables.

   • Research reagents
   • Rapid prototyping
   • Plastic reduction

8. Takasago International Corporation

   Headquarters: Osaka, Japan
   Key Offering: Chiral intermediates for pharmaceuticals and fine chemicals

   Takasago’s asymmetric synthesis platform delivers high enantiomeric excess, supporting the development of next‑generation drugs. Its strong quality management system meets stringent regulatory requirements.

   Sustainability Initiatives: Implementation of water‑recycling systems in production facilities.

   • Asymmetric synthesis
   • Quality management
   • Water recycling

9. PCAS

   Headquarters: Lyon, France
   Key Offering: Custom chiral synthesis services for specialty chemicals

   PCAS offers tailored chiral synthesis solutions, enabling clients to access unique enantiomeric configurations. The company’s agile manufacturing model supports rapid scale‑up for emerging applications.

   Sustainability Initiatives: Adoption of green chemistry guidelines and low‑energy synthesis routes.

   • Custom synthesis
   • Agile manufacturing
   • Low‑energy processes

10. Curia Global Inc.

    Headquarters: Atlanta, USA
    Key Offering: High‑purity chiral intermediates for pharmaceuticals and agrochemicals

    Curia’s focus on precision chemistry ensures consistent optical purity, making its chiral alcohols a trusted component in complex synthetic routes. The company’s global distribution network facilitates timely delivery to key markets.

    Sustainability Initiatives: Commitment to carbon neutrality across its supply chain.

    • Precision chemistry
    • Global distribution
    • Carbon neutrality

Download FREE Sample Report

Get Full Report

Market Outlook

The trajectory of the (S)-2‑Hexanol market is shaped by the continued rise of chiral drug development and the expansion of single‑enantiomer agrochemicals. As regulatory frameworks increasingly mandate the demonstration of safety and efficacy for each enantiomer, demand for high‑purity intermediates is expected to grow. Concurrently, the shift toward bio‑based production methods and enzymatic synthesis will drive cost efficiencies, enabling broader adoption across specialty chemical sectors.

Emerging Trends

• Advances in biocatalytic platforms that lower energy consumption and increase scalability.
• Integration of digital process control for real‑time monitoring of enantiomeric excess.
• Growing emphasis on life‑cycle assessment to evaluate environmental impact of chiral intermediates.
• Expansion of chiral auxiliaries in agrochemical synthesis to meet stricter environmental regulations.